After Hours
$
7.34
Change
+0.05 +0.69%
Volume
Volume 6,141
Jan 27, 2023, 7:54 p.m.
Quotes are delayed by 20 min
Previous close
$ 6.94
$ 7.29
Change
+0.35 +5.04%
Day low
Day high
$6.89
$7.39

52 week low
52 week high
$4.89
$13.19

Market cap
$444.70M
Average volume
573,946
P/E ratio
N/A
Rev. per Employee
$128,465
EPS
-1.50
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on CRBU
-
Gene-Editor Crispr Therapeutics CEO Sees Positive Catalysts Ahead
- Barron's Online
-
Intellia Stock Has Tumbled. There Are Issues With Gene-Editing Patents.
- Barron's Online
-
These 3 Funds Invest Like ARK But Didn’t Fall as Far
- Barron's Online
-
Pfizer and Beam Partner to Develop Treatments for 3 Genetic Diseases
- Barron's Online
-
Caribou Biosciences started at outperform with $36 stock price target at Oppenheimer
- Tomi Kilgore
-
Prime Is the Newest Gene Editing, and It's Getting Better
- Barron's Online
-
Caribou Biosciences started at buy with $30 stock price target at BofA Securities
- Tomi Kilgore
-
7 Companies Open for Trading. Here's How They Did.
- Barron's Online
Other News on CRBU
-
Tradeweb Exchange-Traded Funds Update - September 2022
- Seeking Alpha
-
Caribou Biosciences (CRBU) Investor Presentation - Slideshow
- Seeking Alpha
-
Caribou Biosciences (CRBU) Corporate Presentation - Slideshow
- Seeking Alpha
-
Caribou Biosciences: Potential To Change CAR-T Landscape
- Seeking Alpha
-
Caribou Biosciences (CRBU) Corporate Presentation - Slideshow
- Seeking Alpha
-
HYMC, AXLA and EVLO among mid-day gainers
- Seeking Alpha
- Loading more headlines...
Press Releases on CRBU
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com